impact factor, citescore
logo
 

LER & CER: letter to Editor Rheumatology

 

Multiple testing in the ‘Canakinumab in atherosclerosis’ trial: correction required?


1, 2

 

  1. Department of Internal Medicine, Division of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey. guzelant_gul@hotmail.com
  2. Department of Cardiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

CER10337
2017 Vol.35, N°2 ,Suppl.104
PI 0024
LER & CER: letter to Editor Rheumatology

Free to view
(click on article PDF icon to read the article)

PMID: 28516876 [PubMed]

Received: 17/02/2017
Accepted : 12/04/2017
In Press: 27/04/2017
Published: 29/05/2017

Rheumatology Article